The influence of thermo-chemotherapy on bladder tumours: An immunohistochemical analysis

World Journal of Urology

Volumn 25, Issue 3, 2007, Pages 303-308

  van der Heijden, Antoine G ^a   Hulsbergen Van de Kaa, Christina A ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Hyperthermia; Ki 67; p53; Superficial bladder cancer

Indexed keywords

EID: 34347213412     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-007-0143-1     Document Type: Article

References (16)

1. Colombo R, Da Pozzo LF, Lev A et al. (1998) Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 159:783-787
2. Colombo R, Da Pozzo LF, Salonia A et al. (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270-4276
3. Colombo R, Lev A, Da Pozzo LF et al. (1995) A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J Urol 153:959-963
4. Fajardo LF (1984) Pathological effects of hyperthermia in normal tissues. Cancer Res 44:4826s-4835s
5. Ferlay J, Bray F, Pisani P et al. (2001) Cancer Incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon
6. Gofrit ON, Shapiro A, Pode D et al. (2004) Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 63:466-471
7. Grossman HB, Liebert M, Antelo M et al. (1998) p53 and RB expression predict progression in T1 bladder cancer. Clin Cancer Res 4:829-834
8. Guan J, Stavridi E, Leeper DB et al. (2002) Effects of hyperthermia on p53 protein expression and activity. J Cell Physiol 190:365-374
9. Hainaut P, Butcher S, Milner J (1995) Temperature sensitivity for conformation is an intrinsic property of wild-type p53. Br J Cancer 71:227-231
10. Kowal CD, Bertino JR (1979) Possible benefits of hyperthermia to chemotherapy. Cancer Res 39:2285-2289
11. Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA (1998) The prevalence of blc-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol 29(2):146-154
12. Parkin DM, Whelan SL, Ferlay J et al. (2003) Cancer incidence in five continents. IARC Press, Lyon
13. Rath-Wolfson L, Moskovitz B, Dekel Y, Kugel V, Koren R (2003) Combined intravesical hyperthermia and mitomycin chemotherapy: A preliminary in vivo study. Int J Exp Pathology 84:145-152
14. van der Heijden AG, Jansen CFJ, Verhaegh G, O'Donnell MA, Schalken JA, Witjes JA (2004) The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol 46(1):670-674
15. van der Heijden AG, Kiemeney LA, Gofrit ON et al. (2004) Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 46:65-72
16. van der Heijden AG, Verhaegh G, Jansen CF, Schalken JA, Witjes JA (2005) Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: An in vitro study. J Urol 173(4):1375-1380